How should acute encephalopathy be evaluated and managed in a 60-year-old woman?

Acute Encephalopathy in a 60-Year-Old Female

In a 60-year-old woman with acute encephalopathy, immediately perform brain MRI and/or EEG, followed by lumbar puncture once infection is ruled out by basic CSF parameters, then initiate high-dose intravenous methylprednisolone empirically if autoimmune encephalitis is suspected and no contraindications exist 1.

Diagnostic Evaluation Algorithm

Step 1: Initial Assessment and Imaging

• Perform brain MRI immediately to identify focal or multifocal brain abnormalities 1
• If MRI unavailable, obtain CT head to exclude hemorrhage, mass effect, or other structural lesions 2, 3
• Obtain EEG to detect focal abnormalities, epileptiform discharges, or subclinical seizures 1, 2

The combination of MRI and EEG provides complementary information—MRI identifies structural and inflammatory changes while EEG detects functional abnormalities that may not be visible on imaging 2.

Step 2: Cerebrospinal Fluid Analysis

Perform lumbar puncture as soon as possible unless contraindicated by mass effect or coagulopathy 1, 4. Test for:

• Cell count and differential (pleocytosis ≥5 WBC/mm³ suggests inflammation) 2
• Protein, glucose, CSF/serum glucose ratio
• Oligoclonal bands, IgG index, and IgG synthesis rate
• HSV-1/2 PCR and VZV PCR (critical to exclude treatable viral encephalitis) 4, 3
• Bacterial and fungal cultures
• Neuronal autoantibodies panel in CSF 1

Note that normal CSF does not exclude autoimmune encephalitis—proceed with antibody testing if clinical suspicion remains high 1.

Step 3: Blood Testing

Send comprehensive panel including:

• Neuronal autoantibodies in serum (more sensitive for LGI1, onconeuronal antibodies) 1
• Complete metabolic panel, liver function tests, ammonia
• Thyroid function tests and antithyroid antibodies
• Vitamin B1/B12 levels
• HIV, inflammatory markers (ESR, CRP)
• ANA, ENA, ANCA if systemic autoimmune disease suspected 4

Step 4: Cancer Screening (Age-Appropriate)

In a 60-year-old woman, perform CT chest/abdomen/pelvis with contrast to screen for occult malignancy, particularly ovarian, breast, or lung cancer 1. If negative and high suspicion for paraneoplastic syndrome:

• Add mammogram or breast MRI
• Pelvic ultrasound
• Consider whole-body FDG-PET 1

Step 5: Consider FDG-PET Brain

If clinical suspicion for autoimmune encephalitis remains high but MRI and other studies are uninformative, brain FDG-PET may show characteristic patterns of hypermetabolism or hypometabolism 1.

Management Algorithm

Immediate Treatment Decisions

Once infection is ruled out by basic CSF results (cell count, Gram stain):

1. Start high-dose IV methylprednisolone (IVMP) 1g daily for 3-5 days if no contraindications 1

   • Contraindications: uncontrolled hypertension, uncontrolled diabetes, acute peptic ulcer, severe behavioral symptoms worsening with steroids 1

2. If steroids contraindicated or patient has high thromboembolic risk/severe hyponatremia:

   • Use IVIG (0.4 g/kg/day for 5 days) first in agitated patients or those with bleeding disorders 1
   • Use plasma exchange (PLEX) first if severe hyponatremia, high cancer risk, or associated demyelination 1

3. For severe presentations (refractory status epilepticus, severe dysautonomia, NMDAR-antibody picture):

   • Start combination therapy immediately: IVMP + IVIG or IVMP + PLEX rather than sequential treatment 1

Escalation Strategy

If no clinical, radiological, or electrophysiological improvement after initial treatment cycle:

• Add second first-line agent (IVIG or PLEX) 1
• If still no improvement after 2-4 weeks of combined first-line therapy, escalate to rituximab 1
• Consider experimental therapies (IL-6 inhibitors, bortezomib) for refractory cases 1

Supportive Management

• Elevate head of bed to 30 degrees 5
• Intubate for airway protection if progressing to grade III-IV encephalopathy 5
• Treat seizures aggressively with antiepileptics 1, 5
• Monitor for and treat infections promptly 5
• Avoid sedation if possible in early stages; use short-acting agents (propofol) if needed 5

Critical Pitfalls to Avoid

1. Do not wait for antibody results before starting immunotherapy—empiric treatment improves outcomes when autoimmune encephalitis is suspected 1

2. Do not assume normal CSF excludes autoimmune encephalitis, especially in immunocompromised patients or early disease 1, 4

3. Do not use lactulose routinely—evidence is limited and it may cause abdominal distention complicating potential transplant 5

4. Do not delay lumbar puncture excessively—if MRI unavailable due to agitation, proceed with LP after screening CT 1

5. In a 60-year-old woman, always screen for malignancy—paraneoplastic syndromes are more common in this age group and require tumor treatment for optimal outcomes 1, 4

6. Test antibodies in both serum AND CSF—sensitivity varies by antibody type (NMDAR more sensitive in CSF; LGI1 more sensitive in serum) 1

Specific Considerations for This Age Group

At age 60, consider:

• Higher risk of paraneoplastic encephalitis (ovarian teratoma less likely than in younger women; consider breast, lung, ovarian carcinoma) 1, 4
• VGKC-complex antibody encephalitis (median age 65 years, presents with profound disorientation, seizures, hyponatremia in 60%) 4
• Metabolic causes more common (hyponatremia, hypoglycemia, hepatic encephalopathy) 6
• Stroke mimics—vascular events are more prevalent in this age group and must be excluded 7, 8

The key is early empiric immunotherapy while awaiting definitive diagnosis, as delayed treatment significantly worsens outcomes in autoimmune encephalitis 1, 4.